The expanding role of primary care in cancer control

The Lancet Oncology

Volumn 16, Issue 12, 2015, Pages 1231-1272

  Rubin, Greg ^a   Berendsen, Annette ^b   Crawford, S Michael ^c   Dommett, Rachel ^d   Earle, Craig ^e   Emery, Jon ^f   Fahey, Tom ^g   Grassi, Luigi ^h   Grunfeld, Eva ^e   Gupta, Sumit ⁱ   Hamilton, Willie ^l   Hiom, Sara ^m   Hunter, David ^a   Lyratzopoulos, Georgios ⁿ   Macleod, Una ^o   Mason, Robert ^p   Mitchell, Geoffrey ^q   Neal, Richard D ^r   Peake, Michael ^s   Roland, Martin ^t   Seifert, Bohumil ^u   Sisler, Jeff ^v   Sussman, Jonathan ^w   Taplin, Stephen ^x   Vedsted, Peter ^y   Voruganti, Teja ^j   Walter, Fiona ^t   Wardle, Jane ⁿ   Watson, Eila ^z   Weller, David ^aa   Wender, Richard ^ab   Whelan, Jeremy ⁿ   Whitlock, James ^k   Wilkinson, Clare ^r   de Wit, Niek ^ac   Zimmermann, Camilla ^j   more..

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Airedale NHS Trust   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^h UNIVERSITY OF FERRARA   (Italy)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY OF EXETER   (United Kingdom)

^m IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

ⁿ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^o UNIVERSITY OF HULL   (United Kingdom)

^p KING'S COLLEGE LONDON   (United Kingdom)

^q UNIVERSITY OF QUEENSLAND   (Australia)

^r BANGOR UNIVERSITY   (United Kingdom)

^s GLENFIELD HOSPITAL   (United Kingdom)

^t UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^u CHARLES UNIVERSITY   (Czech Republic)

^v UNIVERSITY OF MANITOBA   (Canada)

^w JURAVINSKI CANCER CENTRE   (Canada)

^x NATIONAL CANCER INSTITUTE   (United States)

^y AARHUS UNIVERSITY   (Denmark)

^z OXFORD BROOKES UNIVERSITY   (United Kingdom)

^aa UNIVERSITY OF EDINBURGH   (United Kingdom)

^ab AMERICAN CANCER SOCIETY   (United States)

^ac UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CAREGIVER; CASE STUDY; CLINICAL ASSESSMENT TOOL; COLORECTAL CANCER; COMMUNITY CARE; DECISION SUPPORT SYSTEM; EARLY DIAGNOSIS; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PRACTITIONER; HEALTH PROMOTION; HELP SEEKING BEHAVIOR; HODGKIN DISEASE; HUMAN; INFORMED CONSENT; INTEGRATED HEALTH CARE SYSTEM; MEDICAL AUDIT; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SPECIALIST; MEDICAL TECHNOLOGY; NONHODGKIN LYMPHOMA; PATIENT CARE; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROFESSIONAL DEVELOPMENT; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; RARE DISEASE; REVIEW; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SYMPTOM; TERMINAL CARE; TESTIS CANCER; HEALTH SERVICE; NEOPLASMS; PROCEDURES;

DELIVERY OF HEALTH CARE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; NEOPLASMS; PRIMARY HEALTH CARE;

EID: 84942576701     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00205-3     Document Type: Review

References (346)

1. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011, 12:933-980.
2. Ahmad AS, Ormiston-Smith N, Sasieni PD Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer 2015, 112:943-947.
3. Aftercare of cancer patients: the role of primary care 2011, Dutch Cancer Society's Signalling Committee on Cancer, Dutch Cancer Society, Amsterdam.
4. Maddams J, Utley M, Møller H Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer 2012, 107:1195-1202.
5. Olesen F, Hansen RP, Vedsted P Delay in diagnosis: the experience in Denmark. Br J Cancer 2009, 101(suppl 2):S5-S8.
6. Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012, 106:1262-1267.
7. Walter F, Webster A, Scott S, Emery J The Andersen model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy 2012, 17:110-118.
8. Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer-determining the patient journey using multiple routine data sets. Br J Cancer 2012, 107:1220-1226.
9. Emery JD, Shaw K, Williams B, et al. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol 2014, 11:38-48.
10. Lyratzopoulos G, Wardle J, Rubin G Rethinking diagnostic delay in cancer: how difficult is the diagnosis?. BMJ 2014, 349:g7400.
11. Walter FM, Rubin G, Bankhead C, et al. Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer 2015, 112(suppl 1):S6-13.
12. Raine R, Wong W, Scholes S, Ashton C, Obichere A, Ambler G Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics. BMJ 2010, 340:b5479.
13. Bottle A, Tsang C, Parsons C, Majeed A, Soljak M, Aylin P Association between patient and general practice characteristics and unplanned first-time admissions for cancer: observational study. Br J Cancer 2012, 107:1213-1219.
14. Sheringham JR, Georghiou T, Chitnis XA, Bardsley M Comparing primary and secondary health-care use between diagnostic routes before a colorectal cancer diagnosis: cohort study using linked data. Br J Cancer 2014, 111:1490-1499.
15. Biswas M, Ades AE, Hamilton W Symptom lead times in lung and colorectal cancers: what are the benefits of symptom-based approaches to early diagnosis?. Br J Cancer 2015, 112:271-277.
16. Suspected cancer: recognition and referral 2015, NICE, National Institute for Health and Care Excellence, London, (accessed July 31, 2015). http://www.nice.org.uk/guidance/ng12.
17. Ford A, Marshall O, Crawford SM UK guidance on diagnosis of ovarian cancer: its impact on services in an acute hospital. European Cancer Congress; Amsterdam; Sept 29, 2013. 3098 (accessed July 31, 2015). http://2013.europeancancercongress.org/Scientific-Programme/Abstract-search?abstractid=6559#.
18. Gerada C, Riley B, Thomas M The 2022 GP-a vision for general practice in the future NHS 2012, Royal College of General Practitioners, London.
19. Neville-Webbe HL, Carser JE, Wong H, et al. The impact of a new acute oncology service in acute hospitals: experience from the Clatterbridge Cancer Centre and Merseyside and Cheshire Cancer Network. Clin Med 2013, 13:565-569.
20. Sammut SJ, Mazhar D Management of febrile neutropenia in an acute oncology service. QJM 2012, 105:327-336.
21. CG80 Early and locally advanced breast cancer: diagnosis and treatment 2009, NICE, National Institute for Health and Care Excellence, London.
22. Senkus E, Kyriakides S, Penault-Llorca F, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013, 24(suppl 6):vi7-v23. the ESMO Guidelines Working Group.
23. Major resections by cancer site, in England. 2006 to 2010 2014, NCIN, National Cancer Intelligence Network short report, London, (accessed July 31, 2015). http://www.ncin.org.uk/view?rid=2947.
24. Forrest LF, Adams J, Rubin G, White M The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study. Thorax 2015, 70:138-145.
25. Framework for professional and administrative development of general practice/family medicine in Europe 1998, WHO, World Health Organization Regional Office for Europe, Copenhagen.
26. Taplin SH, Weaver S, Chollette V, et al. Teams and teamwork during a cancer diagnosis: interdependency within and between teams. J Oncol Pract 2015, 11:231-238.
27. Starfield B, Shi L, Macinko J Contribution of primary care to health systems and health. Milbank Q 2005, 83:457-502.
28. Goodwin N, Dixon A, Poole T, Raleigh V Improving the quality of care in general practice 2011, The King's Fund, London.
29. Hunter DJ, Reddy KS Noncommunicable diseases. N Engl J Med 2013, 369:1336-1343.
30. Engaging patients in their health: how the NHS needs to change 2011, The King's Fund, London, (accessed Aug 23, 2015). https://www.kingsfund.org.uk/sites/files/kf/Engaging-Patients-in-their-Health-How-the-NHS-needs-to-change-Anna-Dixon-Kings-Fund-October-2008.pdf, A. Dixon (Ed.).
31. Smith J, Holder H, Edwards N, et al. Securing the future of general practice-new models of primary care 2013, The Kings Fund & Nuffield Trust, London.
32. Mercer SW, Watt GCM The inverse care law: clinical primary care encounters in deprived and affluent areas of Scotland. Ann Fam Med 2007, 5:503-510.
33. Woods LM, Rachet B, Coleman MP Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006, 17:5-19.
34. Crawford SM, Sauerzapf V, Haynes R, Zhao H, Forman D, Jones AP Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer 2009, 101:897-901.
35. van Doorslaer E, Masseria C, Koolman X Inequalities in access to medical care by income in developed countries. CMAJ 2006, 174:177-183. the OECD Health Equity Research Group.
36. Glazier RH, Agha MM, Moineddin R, Sibley LM Universal health insurance and equity in primary care and specialist office visits: a population-based study. Ann Fam Med 2009, 7:396-405.
37. White M, Adams J, Heywood P How and why do interventions that increase health overall widen inequalities within populations?. Health, inequality and society 2009, 65-83. Policy Press, Bristol. S. Babones (Ed.).
38. Forrest LF, Adams J, White M, Rubin G Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study. Br J Cancer 2014, 111:1843-1851.
39. Din NU, Ukoumunne OC, Rubin G, et al. Age and gender variations in cancer diagnostic intervals in 15 cancers: analysis of data from the UK Clinical Practice Research Datalink. PLoS One 2015, 10:e0127717.
40. Brown S, Castelli M, Hunter DJ, et al. How might healthcare systems influence speed of cancer diagnosis: a narrative review. Soc Sci Med 2014, 116:56-63.
41. Watt G Occasional paper 89. General practitioners at the deep end: the experience and views of general practitioners working in the most severely deprived areas of Scotland 2012, Royal College of General Practitioners, London.
42. Macleod U, Ross S, Twelves C, George WD, Gillis C, Watt GCM Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records. BMJ 2000, 320:1442-1445.
43. Campbell SM, Hann M, Hacker J, et al. Identifying predictors of high quality care in English general practice: observational study. BMJ 2001, 323:784-787.
44. Vedsted P, Olesen F Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study. Br J Gen Pract 2011, 61:e508-e512.
45. Hulscher MEWM, Wensing M, van Der Weijden T, Grol R Interventions to implement prevention in primary care. Cochrane Database Syst Rev 2001, 1. CD000362.
46. Fleming P, Godwin M Lifestyle interventions in primary care: systematic review of randomized controlled trials. Can Fam Physician 2008, 54:1706-1713.
47. Bully P, Sánchez Á, Zabaleta-Del-Olmo E, Pombo H, Grandes G Evidence from interventions based on theoretical models for lifestyle modification (physical activity, diet, alcohol and tobacco use) in primary care settings: a systematic review. Prev Med 2015, 76S:S76-S93.
48. Zwar NA, Mendelsohn CP, Richmond RL Supporting smoking cessation. BMJ 2014, 348:f7535.
49. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T Physician advice for smoking cessation. Cochrane Database Syst Rev 2013, 5. CD000165.
50. Hartmann-Boyce J, Lancaster T, Stead LF Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev 2014, 6. CD001118.
51. Papadakis S, McDonald P, Mullen K-A, Reid R, Skulsky K, Pipe A Strategies to increase the delivery of smoking cessation treatments in primary care settings: a systematic review and meta-analysis. Prev Med 2010, 51:199-213.
52. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013, 382:1629-1637.
53. Kaner EF, Dickinson HO, Beyer F, et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev 2009, 28:301-323.
54. Rubak S, Sandbaek A, Lauritzen T, Christensen B Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005, 55:305-312.
55. O'Donnell A, Anderson P, Newbury-Birch D, et al. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcohol 2014, 49:66-78.
56. Jackson SE, Wardle J, Johnson F, Finer N, Beeken RJ The impact of a health professional recommendation on weight loss attempts in overweight and obese British adults: a cross-sectional analysis. BMJ Open 2013, 3:e003693.
57. Carvajal R, Wadden TA, Tsai AG, Peck K, Moran CH Managing obesity in primary care practice: a narrative review. Ann N Y Acad Sci 2013, 1281:191-206.
58. Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. BMJ 2011, 343:d6500.
59. Elley CR, Kerse N, Arroll B, Robinson E Effectiveness of counselling patients on physical activity in general practice: cluster randomised controlled trial. BMJ 2003, 326:793.
60. Orrow G, Kinmonth A-L, Sanderson S, Sutton S Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials. BMJ 2012, 344:e1389.
61. Smith LK, Pope C, Botha JL Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 2005, 366:825-831.
62. Forbes LJ, Simon AE, Warburton F, et al. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?. Br J Cancer 2013, 108:292-300. the International Cancer Benchmarking Partnership Module 2 Working Group.
63. Simon AE, Waller J, Robb K, Wardle J Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomarkers Prev 2010, 19:2272-2277.
64. Whitaker KL, Scott SE, Winstanley K, Macleod U, Wardle J Attributions of cancer 'alarm' symptoms in a community sample. PLoS One 2014, 9:e114028.
65. Whitaker KL, Macleod U, Winstanley K, Scott SE, Wardle J Help seeking for cancer 'alarm' symptoms: a qualitative interview study of primary care patients in the UK. Br J Gen Pract 2015, 65:e96-105.
66. Renzi C, Whitaker KL, Wardle J Over-reassurance and undersupport after a 'false alarm': a systematic review of the impact on subsequent cancer symptom attribution and help seeking. BMJ Open 2015, 5:e007002.
67. Lyratzopoulos G, Liu MP-H, Abel GA, Wardle J, Keating NL The association between fatalistic beliefs and late stage at diagnosis of lung and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2015, 24:720-726.
68. Andersen RS, Tørring ML, Vedsted P Global health care-seeking discourses facing local clinical realities: exploring the case of cancer. Med Anthropol Q 2014, 29:237-255.
69. Scott SE, Grunfeld EA, Auyeung V, McGurk M Barriers and triggers to seeking help for potentially malignant oral symptoms: implications for interventions. J Public Health Dent 2009, 69:34-40.
70. Bankhead C, Heneghan C, Hewitson P, Thompson M Safety netting recommendations for primary care: development of consensus guidelines 2014, Cancer Research UK, Oxford.
71. Ironmonger L, Ohuma E, Ormiston-Smith N, Gildea C, Thomson C, Peake M 43: The impact of a national public awareness campaign for cough as a lung cancer symptom. Lung Cancer 2015, 87(suppl 1):S17.
72. Gøtzsche PC, Nielsen M Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009, 4. CD001877.
73. Claassen L, Henneman L, Janssens ACJ, et al. Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence. BMC Public Health 2010, 10:248.
74. Qureshi N, Carroll JC, Wilson B, et al. The current state of cancer family history collection tools in primary care: a systematic review. Genet Med 2009, 11:495-506.
75. Walter FM, Emery JD Genetic advances in medicine: has the promise been fulfilled in general practice?. Br J Gen Pract 2012, 62:120-121.
76. Seifert B, Bulc M Colorectal cancer screening: manual for general practitioners 2013, Maxdorf Publishing, Prague.
77. Jepson RG, Forbes CA, Sowden AJ, Lewis RA Increasing informed uptake and non-uptake of screening: evidence from a systematic review. Health Expect 2001, 4:116-126.
78. Harris MA, Byles JE, Cockburn J, D'Este C A general practice-based recruitment strategy for colorectal cancer screening. Aust N Z J Public Health 2000, 24:441-443.
79. Brawarsky P, Brooks DR, Mucci LA, Wood PA Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detect Prev 2004, 28:260-268.
80. Seifert B, Zavoral M, Fric P, Bencko V The role of primary care in colorectal cancer screening: experience from Czech Republic. Neoplasma 2008, 55:74-80.
81. Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Br J Cancer 2011, 105:475-480.
82. Wee CC, McCarthy EP, Phillips RS Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005, 41:23-29.
83. Ferreira MR, Dolan NC, Fitzgibbon ML, et al. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol 2005, 23:1548-1554.
84. Walsh JM, Salazar R, Terdiman JP, Gildengorin G, Pérez-Stable EJ Promoting use of colorectal cancer screening tests. Can we change physician behavior?. J Gen Intern Med 2005, 20:1097-1101.
85. Jepson RG, Hewison J, Thompson AG, Weller D How should we measure informed choice? The case of cancer screening. J Med Ethics 2005, 31:192-196.
86. Marteau TM, Dormandy E, Michie S A measure of informed choice. Health Expect 2001, 4:99-108.
87. O'Connor AM, Rostom A, Fiset V, et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ 1999, 319:731-734.
88. Smith EC, Ziogas A, Anton-Culver H Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults. Cancer 2012, 118:6179-6187.
89. Epelam S, Epelman C, Erwenne C, et al. National campaign for early diagnosis of retinoblastoma in Brazil. J Clin Oncol 2004, 22(July 15 Supplement):8561.
90. Reinhardt D, Creutzig U Isolated myelosarcoma in children-update and review. Leuk Lymphoma 2002, 43:565-574.
91. Baker J Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia and Hodgkin disease: a population-based study 2010, University of Toronto, Toronto.
92. Crawford SC, Davis JA, Siddiqui NA, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 2002, 325:196.
93. Gupta S, Gibson P, Pole JD, Sutradhar R, Sung L, Guttmann A Predictors of diagnostic interval and associations with outcome in acute lymphoblastic leukemia. Pediatr Blood Cancer 2015, 62:957-963.
94. Dang-Tan T, Franco EL Diagnosis delays in childhood cancer: a review. Cancer 2007, 110:703-713.
95. Brasme JF, Morfouace M, Grill J, et al. Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits. Lancet Oncol 2012, 13:e445-e459.
96. Lethaby CD, Picton S, Kinsey SE, Phillips R, van Laar M, Feltbower RG A systematic review of time to diagnosis in children and young adults with cancer. Arch Dis Child 2013, 98:349-355.
97. Tørring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer 2013, 49:2187-2198.
98. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014, 64:83-103.
99. Dommett RM, Redaniel MT, Stevens MC, Hamilton W, Martin RM Features of childhood cancer in primary care: a population-based nested case-control study. Br J Cancer 2012, 106:982-987.
100. Dommett RM, Redaniel T, Stevens MC, Martin RM, Hamilton W Risk of childhood cancer with symptoms in primary care: a population-based case-control study. Br J Gen Pract 2013, 63:e22-e29.
101. Ahrensberg JM, Hansen RP, Olesen F, Schrøder H, Vedsted P Presenting symptoms of children with cancer: a primary-care population-based study. Br J Gen Pract 2012, 62:e458-e465.
102. Ahrensberg JM, Olesen F, Hansen RP, Schrøder H, Vedsted P Childhood cancer and factors related to prolonged diagnostic intervals: a Danish population-based study. Br J Cancer 2013, 108:1280-1287.
103. Dixon-Woods M, Findlay M, Young B, Cox H, Heney D Parents' accounts of obtaining a diagnosis of childhood cancer. Lancet 2001, 357:670-674.
104. Ahrensberg JM, Schrøder H, Hansen RP, Olesen F, Vedsted P The initial cancer pathway for children-one-fourth wait more than 3 months. Acta Paediatr 2012, 101:655-662.
105. Arksey H, Sloper P Disputed diagnoses: the cases of RSI and childhood cancer. Soc Sci Med 1999, 49:483-497.
106. Saha V, Love S, Eden T, Micallef-Eynaud P, MacKinlay G Determinants of symptom interval in childhood cancer. Arch Dis Child 1993, 68:771-774.
107. Pollock BH, Krischer JP, Vietti TJ Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr 1991, 119:725-732.
108. Kyle RG, Forbat L, Hubbard G Cancer awareness among adolescents in Britain: a cross-sectional study. BMC Public Health 2012, 12:580.
109. Van den Bruel A, Aertgeerts B, Bruyninckx R, Aerts M, Buntinx F, Buntinx F Signs and symptoms for diagnosis of serious infections in children: a prospective study in primary care. Br J Gen Pract 2007, 57:538-546.
110. Fijten GH, Blijham GH Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract 1988, 27:373-376.
111. Hamilton W, Sharp DJ, Peters TJ, Round AP Clinical features of prostate cancer before diagnosis: a population-based, case-control study. Br J Gen Pract 2006, 56:756-762.
112. Dommett RM, Redaniel MT, Stevens MCG, Hamilton W, Martin RM Features of cancer in teenagers and young adults in primary care: a population-based nested case-control study. Br J Cancer 2013, 108:2329-2333.
113. Banks J, Hollinghurst S, Bigwood L, Peters TJ, Walter FM, Hamilton W Preferences for cancer investigation: a vignette-based study of primary-care attendees. Lancet Oncol 2014, 15:232-240.
114. Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015, 112(suppl 1):S92-107.
115. Mendonca SC, Abel GA, Saunders CL, Wardle J, Lyratzopoulos G Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the English Cancer Patient Experience Survey. Eur J Cancer Care (Engl) 2015, published online July 30. 10.1111/ecc.12353.
116. Knottnerus JA Medical decision making by general practitioners and specialists. Fam Prac 1991, 8:305-307.
117. Winkens R, Dinant GJ Evidence base of clinical diagnosis: rational, cost effective use of investigations in clinical practice. BMJ 2002, 324:783.
118. Elstein AS, Schwartz A Clinical problem solving and diagnostic decision making: selective review of the cognitive literature. BMJ 2002, 324:729-732.
119. The evidence base of clinical diagnosis 2001, BMJ Books, London. J.A. Knottnerus (Ed.).
120. Willis BH, Beebee H, Lasserson DS Philosophy of science and the diagnostic process. Fam Pract 2013, 30:501-505.
121. Andersen RS, Vedsted P, Olesen F, Bro F, Søndergaard J Does the organizational structure of health care systems influence care-seeking decisions? A qualitative analysis of Danish cancer patients' reflections on care-seeking. Scand J Prim Health Care 2011, 29:144-149.
122. Ridd MJ, Ferreira DL, Montgomery AA, Salisbury C, Hamilton W Patient-doctor continuity and diagnosis of cancer: electronic medical records study in general practice. Br J Gen Pract 2015, 65:e305-e311.
123. Irving G, Holden J The time-efficiency principle: time as the key diagnostic strategy in primary care. Fam Pract 2013, 30:386-389.
124. Van Hout AM, de Wit NJ, Rutten FH, Peeters PH Determinants of patient's and doctor's delay in diagnosis and treatment of colorectal cancer. Eur J Gastroenterol Hepatol 2011, 23:1056-1063.
125. Rubin G, Walter F, Emery J, Neal R, Hamilton W, Wardle J Research into practice: prompt diagnosis of cancer in primary care. Br J Gen Pract 2014, 64:428-430.
126. Hamilton W The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer 2009, 101(suppl 2):S80-S86.
127. Stapley S, Peters TJ, Neal RD, Rose PW, Walter FM, Hamilton W The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case-control study using electronic records. Br J Cancer 2013, 108:25-31.
128. Hippisley-Cox J, Coupland C Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2013, 63:e11-e21.
129. Hippisley-Cox J, Coupland C QCancer (accessed Aug 23, 2015). http://www.qcancer.org/.
130. Jones R, Latinovic R, Charlton J, Gulliford MC Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007, 334:1040.
131. Olde Bekkink M, McCowan C, Falk GA, Teljeur C, Van de Laar FA, Fahey T Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancer. Br J Cancer 2010, 102:48-58.
132. Hippisley-Cox J, Coupland C Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2012, 62:e29-e37.
133. Galvin R, Joyce D, Downey E, Boland F, Fahey T, Hill AK Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study. BMC Cancer 2014, 14:743.
134. Hippisley-Cox J, Coupland C Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2011, 61:e715-e723.
135. Walter FM, Prevost AT, Vasconcelos J, et al. Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study. Br J Gen Pract 2013, 63:e345-e353.
136. Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 2012, 13:353-365.
137. Neal RD, Din NU, Hamilton W, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer 2014, 110:584-592.
138. Shim J, Brindle L, Simon M, George S A systematic review of symptomatic diagnosis of lung cancer. Fam Pract 2014, 31:137-148.
139. Mitchell ED, Rubin G, Macleod U Understanding diagnosis of lung cancer in primary care: qualitative synthesis of significant event audit reports. Br J Gen Pract 2013, 63:e37-e46.
140. Stapley S, Sharp D, Hamilton W Negative chest X-rays in primary care patients with lung cancer. Br J Gen Pract 2006, 56:570-573.
141. Shephard EA, Neal RD, Rose P, Walter FM, Litt EJ, Hamilton WT Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records. Br J Gen Pract 2015, 65:e106-e113.
142. Rubin G, Saunders CL, Abel GA, McPhail S, Lyratzopoulos G, Neal RD Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data. Br J Cancer 2015, 112:676-687.
143. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005, 293:1223-1238.
144. Roshanov PS, You JJ, Dhaliwal J, et al. Can computerized clinical decision support systems improve practitioners' diagnostic test ordering behavior? A decision-maker-researcher partnership systematic review. Implement Sci 2011, 6:88. the CCDSS Systematic Review Team.
145. Hamilton W, Green T, Martins T, Elliott K, Rubin G, Macleod U Evaluation of risk assessment tools for suspected cancer in general practice: a cohort study. Br J Gen Pract 2013, 63:e30-e36.
146. Support MC Electronic cancer decision support tools (eCDS). Project summary and update 2014, Macmillan Cancer Support, London.
147. Chiang PP-C, Glance D, Walker J, Walter FM, Emery JD Implementing a QCancer risk tool into general practice consultations: an exploratory study using simulated consultations with Australian general practitioners. Br J Cancer 2015, 112(suppl 1):S77-S83.
148. Stein KD, Syrjala KL, Andrykowski MA Physical and psychological long-term and late effects of cancer. Cancer 2008, 112(suppl):2577-2592.
149. Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 2000, 163:181-186.
150. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013, 368:987-998.
151. Throwing light on the consequences of cancer and its treatment 2013, Macmillan Cancer Support, Macmillan Cancer Support, London, (accessed July 31, 2015). http://www.ncsi.org.uk/wp-content/uploads/MAC14312_CoT_Throwing-light_report_FINAL.pdf.
152. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355:1572-1582. the Childhood Cancer Survivor Study.
153. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007, 109:1878-1886.
154. Haugnes HS, Bosl GJ, Boer H, et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 2012, 30:3752-3763.
155. Barnett GC, West CML, Dunning AM, et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 2009, 9:134-142.
156. Brandenbarg D, Roorda C, Groenhof F, et al. Increased primary health care use in the first year after colorectal cancer diagnosis. Scand J Prim Health Care 2014, 32:55-61.
157. Khan NF, Watson E, Rose PW Primary care consultation behaviours of long-term, adult survivors of cancer in the UK. Br J Gen Pract 2011, 61:197-199.
158. Late effects of treatment for children's cancer Children's Oncology Group, (accessed Aug 23, 2015). https://childrensoncologygroup.org/index.php/lateeffectsoftreatment.
159. Andreyev HJN, Davidson SE, Gillespie C, Allum WH, Swarbrick E Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 2012, 61:179-192.
160. Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006, 24:5091-5097. the American Society of Clinical Oncology.
161. Walter FM, Usher-Smith J, Yadlapalli S, Watson E. Caring for people living with and beyond cancer: an online survey of English GPs. Br J Gen Pract (in press).
162. Berendsen AJ, Groot Nibbelink A, Blaauwbroek R, Berger MY, Tissing WJE Second cancers after childhood cancer-GPs beware!. Scand J Prim Health Care 2013, 31:147-152.
163. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011, 12:160-174.
164. Jamie K, Collins B Frissure: prose poems and artworks 2013, Polygon Books, Edinburgh.
165. Foster C, Wright D, Hill H, Hopkinson J, Roffe L Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eur J Cancer Care (Engl) 2009, 18:223-247.
166. Hoekstra RA, Heins MJ, Korevaar JC Health care needs of cancer survivors in general practice: a systematic review. BMC Fam Pract 2014, 15:94.
167. Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 2014, 32:1605-1619. the American Society of Clinical Oncology.
168. Northouse L, Williams AL, Given B, McCorkle R Psychosocial care for family caregivers of patients with cancer. J Clin Oncol 2012, 30:1227-1234.
169. Psychopharmacology in oncology and palliative care. A practical manual 2014, Springer-Verlag, Berlin/New York. L. Grassi, M. Riba (Eds.).
170. Handbook of psychotherapy 2011, Wiley-Blackwell, New York. M. Watson, D. Kissane (Eds.).
171. Schnipper LE, Lyman GH, Blayney DW, Hoverman JR, Raghavan D, Wollins DS Schilsker. American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol 2013, 31:4362-4370.
172. Schapira DV, Urban N A minimalist policy for breast cancer surveillance. JAMA 1991, 265:380-382.
173. Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. Am Soc Clin Oncol Educ Book 2014, 2014:e57-e67.
174. Salani R, Backes FJ, Fung MF, et al. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol 2011, 204:466-478.
175. Crnalic S, Hildingsson C, Bergh A, Widmark A, Svensson O, Löfvenberg R Early diagnosis and treatment is crucial for neurological recovery after surgery for metastatic spinal cord compression in prostate cancer. Acta Oncol 2013, 52:809-815.
176. Spiro SG, Gould MK, Colice GL Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007, 132(suppl):149S-160S. the American College of Chest Physicians.
177. Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013, 31:961-965. the American Society of Clinical Oncology.
178. Thompson CA, Ghesquieres H, Maurer MJ, et al. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol 2014, 32:3506-3512.
179. NCCN guidelines for treatment of cancer by site National Comprehensive Cancer Network, (accessed Aug 23, 2015). http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.
180. Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013, 31:4465-4470. the American Society of Clinical Oncology.
181. van Geel AN, Pastorino U, Jauch KW, et al. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 1996, 77:675-682.
182. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 2005, 48:77-81.
183. Anderson JE, Litzow MR, Appelbaum FR, et al. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. J Clin Oncol 1993, 11:2342-2350.
184. Renehan AG, Egger M, Saunders MP, O'Dwyer ST Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002, 324:813.
185. Ibrahim EM, Al-Homaidh A Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol 2011, 28:753-765.
186. Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006, 24:3527-3534.
187. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 2011, 29:726-732.
188. Move more. Physical activity the underrated 'wonder drug' 2011, Macmillan Cancer Support, Macmillan Cancer Support, London, London, (accessed July 31, 2015). http://www.macmillan.org.uk/Documents/AboutUs/Health_professionals/PhysicalActivityUnderatedWonderdrug.pdf.
189. Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007, 342-347. World Cancer Research Fund/American Institute for Cancer Research, American Institute for Cancer Research, Washington DC.
190. Roorda C, Berendsen AJ, Haverkamp M, van der Meer K, de Bock GH Discharge of breast cancer patients to primary care at the end of hospital follow-up: a cross-sectional survey. Eur J Cancer 2013, 49:1836-1844.
191. Watson EK, O'Brien R, Campbell C, et al. Views of health professionals on the role of primary care in the follow-up of men with prostate cancer. Fam Pract 2011, 28:647-654. the Prostate Cancer Follow-Up Study Group.
192. Lewis RA, Neal RD, Henry M, et al. Patients' and health care professionals' views of cancer follow-up: systematic review. Br J Gen Pract 2009, 59:e248-e259.
193. From cancer patient to cancer survivor: lost in transition 2005, Institute of Medicine, National Academies Press, Washington DC.
194. Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB Survivorship care plans in research and practice. CA Cancer J Clin 2012, 62:101-117.
195. Grunfeld E, Julian JA, Pond G, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 2011, 29:4755-4762.
196. Brothers BM, Easley A, Salani R, Andersen BL Do survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol 2013, 129:554-558.
197. Hershman DL, Greenlee H, Awad D, et al. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat 2013, 138:795-806.
198. Earle CC, Ganz PA Cancer survivorship care: don't let the perfect be the enemy of the good. J Clin Oncol 2012, 30:3764-3768.
199. Grunfeld E, Mant D, Yudkin P, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ 1996, 313:665-669.
200. Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006, 24:848-855.
201. Wattchow DA, Weller DP, Esterman A, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006, 94:1116-1121.
202. Lewis RA, Neal RD, Williams NH, et al. Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract 2009, 59:e234-e247.
203. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010 2012, Australian Institute of Health and Welfare, Australian Institute of Health and Welfare, Canberra, ACT.
204. Ko W, Miccinesi G, Beccaro M, et al. Factors associated with fulfilling the preference for dying at home among cancer patients: the role of general practitioners. J Palliat Care 2014, 30:141-150. the EURO IMPACT.
205. Mitchell GK, Burridge LH, Colquist SP, Love A General practitioners' perceptions of their role in cancer care and factors which influence this role. Health Soc Care Community 2012, 20:607-616.
206. Burt J, Shipman C, White P, Addington-Hall J Roles, service knowledge and priorities in the provision of palliative care: a postal survey of London GPs. Palliat Med 2006, 20:487-492.
207. Rhee JJ, Zwar N, Vagholkar S, Dennis S, Broadbent AM, Mitchell G Attitudes and barriers to involvement in palliative care by Australian urban general practitioners. J Palliat Med 2008, 11:980-985.
208. Yamagishi A, Morita T, Miyashita M, et al. Providing palliative care for cancer patients: the views and exposure of community general practitioners and district nurses in Japan. J Pain Symptom Manage 2012, 43:59-67.
209. Murray SA, Sheikh A Palliative care beyond cancer: care for all at the end of life. BMJ 2008, 336:958-959.
210. Aabom B, Kragstrup J, Vondeling H, Bakketeig LS, Stovring H Does persistent involvement by the GP improve palliative care at home for end-stage cancer patients?. Palliat Med 2006, 20:507-512.
211. Burge F, Lawson B, Johnston G Family physician continuity of care and emergency department use in end-of-life cancer care. Med Care 2003, 41:992-1001.
212. Grande GE, Farquhar MC, Barclay SI, Todd CJ Valued aspects of primary palliative care: content analysis of bereaved carers' descriptions. Br J Gen Pract 2004, 54:772-778.
213. Hanratty B Palliative care provided by GPs: the carer's viewpoint. Br J Gen Pract 2000, 50:653-654.
214. Neergaard MA, Olesen F, Jensen AB, Sondergaard J Palliative care for cancer patients in a primary health care setting: bereaved relatives' experience, a qualitative group interview study. BMC Palliat Care 2008, 7:1.
215. Murray SA, Firth A, Schneider N, et al. Promoting palliative care in the community: production of the primary palliative care toolkit by the European Association of Palliative Care Taskforce in primary palliative care. Palliat Med 2015, 29:101-111.
216. Stjernswärd J, Foley KM, Ferris FD The public health strategy for palliative care. J Pain Symptom Manage 2007, 33:486-493.
217. Strengthening of palliative care as a component of integrated treatment throughout the life course. Resolution EB134/28 2013, WHO, World Health Organization, Geneva, (accessed July 31, 2015). http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_28-en.pdf.
218. World Health Organization essential medicines in palliative care executive summary 2013. Houston, TX: International Association for Hospice and Palliative Care International Association for Hospice and Palliative Care, (accessed May 1, 2014). http://www.who.int/selection_medicines/committees/expert/19/applications/PalliativeCare_8_A_R.pdf.
219. IAPC list of essential medicines for palliative care 2007. Houston, TX: International Association for Hospice and Palliative Care International Association for Hospice and Palliative Care, (accessed May 1, 2014). http://hospicecare.com/resources/palliative-care-essentials/iahpc-essential-medicines-for-palliative-care/.
220. Groot MM, Vernooij-Dassen MJ, Verhagen SC, Crul BJ, Grol RP Obstacles to the delivery of primary palliative care as perceived by GPs. Palliat Med 2007, 21:697-703.
221. Grol R, Giesen P, van Uden C After-hours care in the United Kingdom, Denmark, and the Netherlands: new models. Health Aff (Millwood) 2006, 25:1733-1737.
222. Hoexum M, Bosveld HE, Schuling J, Berendsen AJ Out-of-hours medical care for terminally ill patients: a survey of availability and preferences of general practitioners. Palliat Med 2012, 26:986-993.
223. Beccaro M, Lora Aprile P, Scaccabarozzi G, Cancian M, Costantini M Survey of Italian general practitioners: knowledge, opinions, and activities of palliative care. J Pain Symptom Manage 2013, 46:335-344.
224. Norman A, Sisler J, Hack T, Harlos M Family physicians and cancer care. Palliative care patients' perspectives. Can Fam Physician 2001, 47:2009-2012. 2015-16.
225. Abarshi EA, Echteld MA, Van den Block L, Donker GA, Deliens L, Onwuteaka-Philipsen BD Recognising patients who will die in the near future: a nationwide study via the Dutch Sentinel Network of GPs. Br J Gen Pract 2011, 61:e371-e378.
226. Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 2003, 327:195-198.
227. Casarett DJ, Fishman JM, Lu HL, et al. The terrible choice: re-evaluating hospice eligibility criteria for cancer. J Clin Oncol 2009, 27:953-959.
228. Hanks H, Veitch PC, Harris MF A rural/urban comparison of the roles of the general practitioner in colorectal cancer management. Aust J Rural Health 2008, 16:376-382.
229. Gorlén T, Gorlén TF, Vass M, Neergaard MA Low confidence among general practitioners in end-of-life care and subcutaneous administration of medicine. Dan Med J 2012, 59:A4407.
230. Mitchell GK How well do general practitioners deliver palliative care? A systematic review. Palliat Med 2002, 16:457-464.
231. de Korte-Verhoef MC, Pasman HR, Schweitzer BP, Francke AL, Onwuteaka-Philipsen BD, Deliens L End-of-life hospital referrals by out-of-hours general practitioners: a retrospective chart study. BMC Fam Pract 2012, 13:89.
232. Hall S, Murchie P, Campbell C, Murray SA Introducing an electronic Palliative Care Summary (ePCS) in Scotland: patient, carer and professional perspectives. Fam Pract 2012, 29:576-585.
233. Halkett GK, Jiwa M, Lobb EA Patients' perspectives on the role of their general practitioner after receiving an advanced cancer diagnosis. Eur J Cancer Care (Engl) 2014, 24:662-672.
234. Groot MM, Vernooij-Dassen MJ, Crul BJ, Grol RP General practitioners (GPs) and palliative care: perceived tasks and barriers in daily practice. Palliat Med 2005, 19:111-118.
235. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014, 383:1721-1730.
236. Jordhøy MS, Fayers P, Saltnes T, Ahlner-Elmqvist M, Jannert M, Kaasa S A palliative-care intervention and death at home: a cluster randomised trial. Lancet 2000, 356:888-893.
237. Bajwah S, Higginson IJ General practitioners' use and experiences of palliative care services: a survey in south east England. BMC Palliat Care 2008, 7:18.
238. Yamamoto R, Kizawa Y, Nakazawa Y, Morita T The palliative care knowledge questionnaire for PEACE: reliability and validity of an instrument to measure palliative care knowledge among physicians. J Palliat Med 2013, 16:1423-1428.
239. Sanderson C, Tieman J CareSearch-online palliative care information for GPs. Aust Fam Physician 2010, 39:341-343.
240. Mahmood-Yousuf K, Munday D, King N, Dale J Interprofessional relationships and communication in primary palliative care: impact of the Gold Standards Framework. Br J Gen Pract 2008, 58:256-263.
241. Improving community palliative care in the UK using the gold standards framework. Ninth Australian Palliative Care conference 2007, Palliative Care Australia, Melbourne, VIC. K. Thomas (Ed.).
242. More Care, Less Pathway. A review of the Liverpool Care Pathway (J Neuberger chair) 2013, Department of Health, Department of Health, London.
243. Moroni M, Zocchi D, Bolognesi D, et al. The 'surprise' question in advanced cancer patients: a prospective study among general practitioners. Palliat Med 2014, 28:959-964. the on behalf of the SUQ-P group.
244. Dudgeon DJ, Knott C, Eichholz M, et al. Palliative Care Integration Project (PCIP) quality improvement strategy evaluation. J Pain Symptom Manage 2008, 35:573-582.
245. Maas EA, Murray SA, Engels Y, Campbell C What tools are available to identify patients with palliative care needs in primary care: a systematic literature review and survey of European practice. BMJ Support Palliat Care 2013, 3:444-451.
246. Kearney MK, Weininger RB, Vachon ML, Harrison RL, Mount BM Self-care of physicians caring for patients at the end of life: "Being connected. . . a key to my survival". JAMA 2009, 301:1155-1164.
247. Waller A, Girgis A, Johnson C, et al. Improving outcomes for people with progressive cancer: interrupted time series trial of a needs assessment intervention. J Pain Symptom Manage 2012, 43:569-581.
248. Daveson BA, Harding R, Shipman C, et al. The real-world problem of care coordination: a longitudinal qualitative study with patients living with advanced progressive illness and their unpaid caregivers. PLoS One 2014, 9:e95523.
249. Abernethy AP, Currow DC, Shelby-James T, et al. Delivery strategies to optimize resource utilization and performance status for patients with advanced life-limiting illness: results from the "palliative care trial" [ISRCTN 81117481]. J Pain Symptom Manage 2013, 45:488-505.
250. Mitchell GK, Del Mar CB, O'Rourke PK, Clavarino AM Do case conferences between general practitioners and specialist palliative care services improve quality of life? A randomised controlled trial (ISRCTN 52269003). Palliat Med 2008, 22:904-912.
251. Mitchell GK, Girgis A, Jiwa M, Sibbritt D, Burridge LH, Senior HE Providing general practice needs-based care for carers of people with advanced cancer: a randomised controlled trial. Br J Gen Pract 2013, 63:e683-e690.
252. Detering KM, Hancock AD, Reade MC, Silvester W The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 2010, 340:c1345.
253. Smith SM, Allwright S, O'Dowd T Does sharing care across the primary-specialty interface improve outcomes in chronic disease? A systematic review. Am J Manag Care 2008, 14:213-224.
254. Taplin SH, Rodgers AB Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care. J Natl Cancer Inst Monogr 2010, 2010:3-10.
255. Haggerty JL Ordering the chaos for patients with multimorbidity. BMJ 2012, 345:e5915.
256. Suter E, Oelke ND, Adair CE, Armitage GD Ten key principles for successful health systems integration. Healthc Q 2009, 13:16-23.
257. Leatt P, Pink GH, Guerriere M Towards a Canadian model of integrated healthcare. Healthc Pap 2000, 1:13-35.
258. Glossary of Health Care Quality Terms Robert Wood Johnson Foundation, (accessed Aug 23, 2015). http://www.rwjf.org/en/library/research/2013/04/quality-equality-glossary.html.
259. Sussman J, Souter L, Grunfeld E, et al. Models of care for cancer survivorship 2012, Cancer Care Ontario, Toronto, ON, (accessed July 31, 2015). https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=258056.
260. Ouwens M, Hulscher M, Hermens R, et al. Implementation of integrated care for patients with cancer: a systematic review of interventions and effects. Int J Qual Health Care 2009, 21:137-144.
261. Oeffinger KC, McCabe MS Models for delivering survivorship care. J Clin Oncol 2006, 24:5117-5124.
262. Vasan A, Ellner A, Lawn SD, et al. Integrated care as a means to improve primary care delivery for adults and adolescents in the developing world: a critical analysis of Integrated Management of Adolescent and Adult Illness (IMAI). BMC Med 2014, 12:6.
263. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011, 33:101-110.
264. Ferrante JM, Gonzalez EC, Pal N, Roetzheim RG Effects of physician supply on early detection of breast cancer. J Am Board Fam Pract 2000, 13:408-414.
265. Roetzheim RG, Pal N, van Durme DJ, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol 2000, 43:211-218.
266. Guldbrandt LM, Rasmussen TR, Rasmussen F, Vedsted P Implementing direct access to low-dose computed tomography in general practice-method, adaption and outcome. PLoS One 2014, 9:e112162.
267. Maruthachalam K, Stoker E, Chaudhri S, Noblett S, Horgan AF Evolution of the two-week rule pathway-direct access colonoscopy vs outpatient appointments: one year's experience and patient satisfaction survey. Colorectal Dis 2005, 7:480-485.
268. Prades J, Espinàs JA, Font R, Argimon JM, Borràs JM Implementing a cancer fast-track programme between primary and specialised care in Catalonia (Spain): a mixed methods study. Br J Cancer 2011, 105:753-759.
269. Jefford M, Baravelli C, Dudgeon P, et al. Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial. J Clin Oncol 2008, 26:2272-2277.
270. Enright K, Grunfeld E, Yun L, et al. Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer. J Oncol Pract 2015, 11:126-132.
271. Walker S, Walker J, Richardson G, et al. Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer. Psychol Med 2014, 44:1451-1460.
272. Tremblay D, Charlebois K, Terret C, Joannette S, Latreille J Integrated oncogeriatric approach: a systematic review of the literature using concept analysis. BMJ Open 2012, 2:e001483.
273. Vistad I, Moy BW, Salvesen HB, Liavaag AH Follow-up routines in gynecological cancer-time for a change?. Acta Obstet Gynecol Scand 2011, 90:707-718.
274. Holtedahl K, Norum J, Anvik T, Richardsen E Do cancer patients benefit from short-term contact with a general practitioner following cancer treatment? A randomised, controlled study. Support Care Cancer 2005, 13:949-956.
275. Wulff CN, Thygesen M, Søndergaard J, Vedsted P Case management used to optimize cancer care pathways: a systematic review. BMC Health Serv Res 2008, 8:227.
276. Borras JM, Albreht T, Audisio R, et al. Policy statement on multidisciplinary cancer care. Eur J Cancer 2014, 50:475-480. the European Partnership Action Against Cancer consensus group.
277. National oesophago-gastric cancer audit 2008,9,10,12,13,14 2008, The NHS Information Centre, National Health Service Information Centre, Leeds, (accessed Aug 23, 2015). http://www.hscic.gov.uk/article/1165/searchcatalogue?q=%22National+Oesophago-Gastric+Cancer+Audits%22&sort=Date&size=10&page=1#top.
278. Reeves S, Perrier L, Goldman J, Freeth D, Zwarenstein M Interprofessional education: effects on professional practice and healthcare outcomes (update). Cochrane Database Syst Rev 2013, 3. CD002213.
279. Watson EK, Rose PW, Neal RD, et al. Personalised cancer follow-up: risk stratification, needs assessment or both?. Br J Cancer 2012, 106:1-5.
280. McCabe MS, Bhatia S, Oeffinger KC, et al. American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol 2013, 31:631-640.
281. Goulart JM, Quigley EA, Dusza S, et al. Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med 2011, 26:1027-1035. the INFORMED (internet curriculum for melanoma early detection) Group.
282. Butler J, Foot C, Bomb M, et al. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Health Policy 2013, 112:148-155. the ICBP Working Group.
283. Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012, 6. CD000259.
284. Freeman HP, Muth BJ, Kerner JF Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 1995, 3:19-30.
285. Wagner EH, Ludman EJ, Aiello Bowles EJ, et al. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol 2014, 32:12-18.
286. Clauser SB, Wagner EH, Aiello Bowles EJ, Tuzzio L, Greene SM Improving modern cancer care through information technology. Am J Prev Med 2011, 40(suppl 2):S198-S207.
287. Eysenbach G The impact of the Internet on cancer outcomes. CA Cancer J Clin 2003, 53:356-371.
288. Snyder CF, Wu AW, Miller RS, Jensen RE, Bantug ET, Wolff AC The role of informatics in promoting patient-centered care. Cancer J 2011, 17:211-218.
289. Afshar AE, Weaver RG, Lin M, et al. Capacity and willingness of patients with chronic noncommunicable diseases to use information technology to help manage their condition: a cross-sectional study. CMAJ Open 2014, 2:E51-E59. the Interdisciplinary Chronic Disease Collaboration.
290. de Jong CC, Ros WJ, Schrijvers G The effects on health behavior and health outcomes of Internet-based asynchronous communication between health providers and patients with a chronic condition: a systematic review. J Med Internet Res 2014, 16:e19.
291. Survival of cancer patients in Europe: the EUROCARE Study 1995, IARC Scientific Publications No 132, Lyon. F. Berrino, M. Sant, V. Verdecchia, R. Capocaccia, T. Hakulinen, J. Esteve (Eds.).
292. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014, 15:23-34. the EUROCARE-5 Working Group.
293. The NHS Cancer Plan: a plan for investment, a plan for reform 2000, Department of Health, Department of Health, London.
294. Cancer reform strategy 2007, Department of Health, Department of Health, London, (accessed July 31, 2015). http://www.nhs.uk/NHSEngland/NSF/Documents/Cancer%20Reform%20Strategy.pdf.
295. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9:730-756. the CONCORD Working Group.
296. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2014, 385:977-1010.
297. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011, 377:127-138. the ICBP Module 1 Working Group.
298. Showcasing our findings and impacts 2014, International Cancer Benchmarking Partnership, Cancer Research UK, London, (accessed July 31, 2015). http://www.cancerresearchuk.org/sites/default/files/icbp_pb_1012214_booklet_final.pdf.
299. Boerma WG, van der Zee J, Fleming DM Service profiles of general practitioners in Europe. European GP task profile study. Br J Gen Pract 1997, 47:481-486.
300. Moth G, Olesen F, Vedsted P Reasons for encounter and disease patterns in Danish primary care: changes over 16 years. Scand J Prim Health Care 2012, 30:70-75.
301. Halm EA, Causino N, Blumenthal D Is gatekeeping better than traditional care? A survey of physicians' attitudes. JAMA 1997, 278:1677-1681.
302. Phillips KA, Haas JS, Liang SY, et al. Are gatekeeper requirements associated with cancer screening utilization?. Health Serv Res 2004, 39:153-178.
303. Jensen H, Tørring ML, Olesen F, Overgaard J, Fenger-Grøn M, Vedsted P Diagnostic intervals before and after implementation of cancer patient pathways-a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer 2015, 15:308.
304. Hiom SC Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. Br J Cancer 2015, 112(suppl 1):S1-S5.
305. Vedsted P, Olesen F A differentiated approach to referrals from general practice to support early cancer diagnosis-the Danish three-legged strategy. Br J Cancer 2015, 112(suppl 1):S65-S69.
306. The ACE programme projects Macmillan Cancer Support, (accessed July 31, 2015). http://www.macmillan.org.uk/Documents/AboutUs/Health_professionals/EarlyDiagnosis/ACEprogramme/ACEprojectsoverview.pdf.
307. Ingeman ML, Ormstrup TE, Vedsted P Direct-access to abdominal ultrasonic investigation from general practice-the role in earlier cancer diagnosis. Fam Pract 2015, 32:205-210.
308. General practice profiles National Cancer Intelligence Network, (accessed Aug 23, 2015). http://www.ncin.org.uk/cancer_information_tools/profiles/gp_profiles.
309. Malnick E The Telegraph (London) June 28, 2014, (accessed July 31, 2015). http://www.telegraph.co.uk/health/healthnews/10933442/GPs-to-be-named-and-shamed-over-cancer-diagnosis.html.
310. Baker D, Middleton E Cervical screening and health inequality in England in the 1990s. J Epidemiol Community Health 2003, 57:417-423.
311. HEDIS & performance measurement National Committee for Quality Assurance, (accessed July 31, 2015). http://www.ncqa.org/HEDISQualityMeasurement.aspx.
312. Mullen KJ, Frank RG, Rosenthal MB Can you get what you pay for? Pay-for-performance and the quality of healthcare providers. Rand J Econ 2010, 41:64-91.
313. Lester H, Schmittdiel J, Selby J, et al. The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators. BMJ 2010, 340:c1898.
314. Roland M, Campbell S Successes and failures of pay for performance in the United Kingdom. N Engl J Med 2014, 370:1944-1949.
315. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002, 136:641-651.
316. Barton MB, Bell P, Sabesan S, Koczwara B What should doctors know about cancer? Undergraduate medical education from a societal perspective. Lancet Oncol 2006, 7:596-601.
317. Klabunde CN, Ambs A, Keating NL, et al. The role of primary care physicians in cancer care. J Gen Intern Med 2009, 24:1029-1036.
318. Yang W, Williams JHHP, Hogan PF, et al. Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage. J Oncol Pract 2014, 10:39-45.
319. Cave J, Woolf K, Dacre J, Potts HWW, Jones A Medical student teaching in the UK: how well are newly qualified doctors prepared for their role caring for patients with cancer in hospital?. Br J Cancer 2007, 97:472-478.
320. Tam VC, Berry S, Hsu T, et al. Oncology education in Canadian undergraduate and postgraduate medical programs: a survey of educators and learners. Curr Oncol 2014, 21:e75-e88.
321. Pavlidis N, Vermorken JB, Stahel R, et al. Undergraduate training in oncology: an ESO continuing challenge for medical students. Surg Oncol 2012, 21:15-21.
322. Starmer D, Jamrozik K, Barton M, Miles S Evaluating curriculum changes in undergraduate cancer education. J Cancer Educ 2004, 19:156-160.
323. Thomas IM, Duncan JL Improving cancer teaching through videoconferenced multidisciplinary team meetings. Med Educ 2013, 47:1133-1134.
324. Cancer education hub Royal College of General Practitioners, (accessed Aug 23, 2015). http://elearning.rcgp.org.uk/course/category.php?id=20.
325. Schichtel M, Rose PW, Sellers C Educational interventions for primary healthcare professionals to promote the early diagnosis of cancer: a systematic review. Educ Prim Care 2013, 24:274-290.
326. Sisler J, McCormack-Speak P Bridging the gap between primary care and the cancer system: the UPCON Network of CancerCare Manitoba. Can Fam Physician 2009, 55:273-278.
327. Sargeant J, Murray A, Gray J, et al. Responding to rising cancer caseloads: family physician learning needs and challenges in cancer care. J Cancer Educ 2005, 20:155-161.
328. Education Program in Cancer Care Cancer Australia, (accessed Aug 23, 2015). http://canceraustralia.gov.au/clinical-best-practice/cancer-learning/general-practice-and-cancer-care/education-program-cancer-care.
329. Frank JR, Mungroo R, Ahmad Y, Wang M, De Rossi S, Horsley T Toward a definition of competency-based education in medicine: a systematic review of published definitions. Med Teach 2010, 32:631-637.
330. Iobst WF, Sherbino J, Cate OT, et al. Competency-based medical education in postgraduate medical education. Med Teach 2010, 32:651-656.
331. Campbell C, Silver I, Sherbino J, Cate OT, Holmboe ES Competency-based continuing professional development. Med Teach 2010, 32:657-662.
332. CanMEDS 2015: Understanding the realities of today's physician Royal College of Physicians and Surgeons in Canada, (accessed Aug 23, 2015). http://www.royalcollege.ca/portal/page/portal/rc/canmeds/canmeds2015.
333. TeamSTEPPS: national implementation Agency for Heathcare Research and Quality, (accessed Aug 23, 2015). http://teamstepps.ahrq.gov/about-2cl_3.htm.
334. Sawyer T, Laubach VA, Hudak J, Yamamura K, Pocrnich A Improvements in teamwork during neonatal resuscitation after interprofessional TeamSTEPPS training. Neonatal Netw 2013, 32:26-33.
335. Brock D, Abu-Rish E, Chiu C-R, et al. Interprofessional education in team communication: working together to improve patient safety. BMJ Qual Saf 2013, 22:414-423.
336. Thomas L, Galla C Building a culture of safety through team training and engagement. BMJ Qual Saf 2013, 22:425-434.
337. Rubin G, McPhail S, Elliott K National audit of cancer diagnosis in primary care 2011, Royal College of General Practitioners, London.
338. Taplin SH Sharing care to achieve the triple aim of health care delivery. J Oncol Pract 2014, 10:306-307.
339. Forsythe LP, Parry C, Alfano CM, et al. Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst 2013, 105:1579-1587.
340. Canadian Cancer Statistics. 2014 2014, Canadian Cancer Society's Advisory Committee on Cancer Statistics, Canadian Cancer Society, Toronto, ON, (accessed Aug 23, 2015). http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2014-EN.pdf.
341. Improving care for people with cancer 2013, Macmillan Cancer Support, Macmillan Cancer Support, London, (accessed July 31, 2015). http://www.macmillan.org.uk/Documents/GetInvolved/Campaigns/Patient-Experience/Improving-care-for-people-with-cancer.pdf.
342. Detsky AS What patients really want from health care. JAMA 2011, 306:2500-2501.
343. Earle CC, Neville BA Under use of necessary care among cancer survivors. Cancer 2004, 101:1712-1719.
344. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995, 273:1026-1031.
345. Hilligoss B, Vogus TJ Navigating care transitions: a process model of how doctors overcome organizational barriers and create awareness. Med Care Res Rev 2015, 72:25-48.
346. Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R Factors in quality care-the case of follow-up to abnormal cancer screening tests-problems in the steps and interfaces of care. J Natl Cancer Inst Monogr 2010, 2010:58-71.